fundvisualizer.com

Victory RS Value CRVACX

Performance (before sales charge)

As of 10/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 09/30/2022
Stock
92.46%
Non-U.S. Stock
4.42%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
3.12%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 09/30/2022

Basic materials

2.29%

Consumer cyclical

12.73%

Financial services

27.02%

Real estate

7.20%

Consumer defensive

3.44%

Health care

7.32%

Utilities

7.77%

Communication services

2.24%

Energy

4.55%

Industrials

12.99%

Technology

9.32%

Top 10 holdings

As of 09/30/2022

Globe Life Inc
4.16%
Progressive Corp
3.71%
Fairfax Financial Holdings Ltd
3.61%
Vistra Corp
3.44%
Federated Hermes Inc Class B
3.37%
Humana Inc
3.14%
Cash
3.12%
Graphic Packaging Holding Co
2.86%
Interactive Brokers Group Inc Class A
2.66%
Fiserv Inc
2.57%
Fund assets

$296.06 Million

Share class

C

Morningstar category

Mid-Cap Value

Expense ratio

2.07%

Investment objective

Growth

Documents